(Q33809637)

29 July 2017

1 reference

title

Perspectives for a vaccine against hepatitis C virus (English)

1 reference

29 July 2017

1 reference

1 reference

2

Houghton M

1 reference

29 July 2017

Abrignani S

1

1 reference

29 July 2017

Hsu HH

series ordinal

3

1 reference

29 July 2017

publication date

1 January 1999

1 reference

29 July 2017

published in

Journal of Hepatology

1 reference

29 July 2017

volume

31 Suppl 1

1 reference

29 July 2017

page(s)

259-263

1 reference

A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980413-9

7 January 2021

Binding of hepatitis C virus to CD81

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980413-9

7 January 2021

High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980413-9

7 January 2021

Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980413-9

7 January 2021

Hepatitis C transmission associated with intravenous immunoglobulins.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980413-9

7 January 2021

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980413-9

7 January 2021

Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980413-9

7 January 2021

T-lymphocyte response to hepatitis C virus in different clinical courses of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980413-9

7 January 2021

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980413-9

7 January 2021

Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980413-9

7 January 2021

Analysis of a successful immune response against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980413-9

7 January 2021

Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980413-9

7 January 2021

Comparative features of hepatitis C virus infection in humans and chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980413-9

7 January 2021

Vaccination of chimpanzees against infection by the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980413-9

7 January 2021

10.1016/S0168-8278(99)80413-9

Identifiers

DOI

1 reference

29 July 2017

1 reference